Breaks Categories: Stock Spotlights

FridayMay 07, 2021 3:58 pm

BioMedNewsBreaks – RYAH Group Inc. Bringing Innovative Tech Solutions to Plant-Based Treatment Market

RYAH Group, a company developing proprietary technology supporting a data-driven approach to health care, understands the value of combining data with analytics, as reflected by the fact that its products merge these two fundamental elements. “The company has created unique products that pair a growing ecosystem of therapeutic plants with top-rated apps, devices and services,” reads a recent article. “RYAH’s easy-to-operate line of products help foster a seamless dose-control experience that generates insightful data, making it simple for doctors, researchers and end-users to hone in on the ideal settings for the best possible treatment outcomes with RYAH Smart Patch, RYAH…

Continue Reading

FridayMay 07, 2021 3:29 pm

BioMedNewsBreaks – Brain Scientific Inc.’s (BRSF) Products Designed to Disrupt EEG Market

Brain Scientific (OTCQB: BRSF), focused on modernizing the brain diagnostic market through cutting-edge technologies, has sought to narrow the wide access-to-neurological-care gap through portable EEGs, teleneurology, on-demand data exchange and AI predictive biomarkers. “By creating cost-efficient, disposable and portable EEGs, BRSF makes neurology care more accessible without putting excess strain on the already overextended neurologist labor pool,” reads a recent article. As a result, the company has directly tackled the shortage of neurologists in the United States. “The company’s commercialized products were designed to disrupt the slow, expensive and cumbersome EEG market with easy-to-use, economical and disposable solutions. These devices…

Continue Reading

FridayMay 07, 2021 3:06 pm

BioMedNewsBreaks – Healthy Extracts Inc. (HYEX) Leads Research and Manufacture of Beneficial Plant-Based Formulations

Healthy Extracts (OTCQB: HYEX) has continued to strengthen its stronghold in the health and lifestyle industry by researching and manufacturing plant-based formulations offering supplements that are beneficial for heart and nerve health. HYEX has broadened its portfolio through acquisitions of unique assets, BergaMet North America and Ultimate Brain Nutrients (“UBN”). “Healthy Extracts Inc. recently announced positive results of clinical studies for two leading products: BergaMet North America’s HERHEART(TM) and Ultimate Brain Nutrients’ Fuel4Thought(TM) Brain Booster,” reads a recent article. “Duke Pitts, CEO of BergaMet North America, stated that HERHEART(TM) is a natural supplement that is scientifically formulated specifically for women…

Continue Reading

FridayMay 07, 2021 1:48 pm

BioMedNewsBreaks – Imagin Medical Inc.’s (CSE: IME) (OTCQB: IMEXF) i/Blue(TM) Imaging System to Enable More Accurate Tumor Resection

Imagin Medical (CSE: IME) (OTCQB: IMEXF), a surgical imaging company, has made notable strides in its quest to offer innovative technology for visualizing cancer. Designed to address the limitations of both white and blue light cystoscopy procedures, IME’s i/Blue(TM) Imaging System displays real-time white and blue light images on the screen simultaneously. This eliminates the need for the surgeon to switch back and forth between images, as is the case with blue light cystoscopy. On the other hand, it addresses the limitation of the white light cystoscopy, which is notorious for not clearly defining the margins between flat tumor and…

Continue Reading

ThursdayMay 06, 2021 3:14 pm

BioMedNewsBreaks – Predictive Oncology Inc. (NASDAQ: POAI) Advancing Solutions for ‘Personalized Medicine at Its Finest’

Predictive Oncology (NASDAQ: POAI) has made several advances in providing cancer treatment solutions. Its subsidiary, TumorGenesis, “specializes in technology that preserves a patient’s unique cancer tissue biological signatures, thereby allowing researchers to study cancer in the laboratory using samples that reflect actual tumors found in a patient,” reads a recent article.  TumorGenesis’ transformational technology enables cell lines from patients to represent more than 90% of ovarian cancer cells, a significant improvement from the existing technologies, which can only represent 1% of ovarian tumor cells. “The result, simply stated, assists health providers in selecting the most effective drug to treat a…

Continue Reading

MondayMay 03, 2021 3:21 pm

BioMedNewsBreaks – XPhyto Therapeutics Corp. (CSE: XPHY) (OTCQB: XPHYF) (FSE: 4XT) Eyes Significant Market Opportunity

XPhyto Therapeutics (CSE: XPHY) (OTCQB: XPHYF) (FSE: 4XT), a bioscience technology accelerator, raised eyebrows when it announced that XPhyto Laboratories Inc., its Alberta subsidiary, added mescaline production to its psychedelic medicine development programs earlier this year (https://ibn.fm/cHwJi). Mescaline has begun attracting legislative attention, much like was the case with cannabis, which gained widening legalization as state after state approved varied uses of hemp and cannabis within their political boundaries. Recently, California Senator Scott Wiener introduced a bill that would decriminalize select hallucinogenics, including mescaline, in part due to research from top medical universities indicating that such substances can have significant benefits…

Continue Reading

FridayApr 30, 2021 12:10 pm

BioMedNewsBreaks – Brain Scientific Inc. (BRSF) Offering Cost-Effective, Efficient BCI Solutions

Brain Scientific (OTCQB: BRSF), focused on modernizing the brain diagnostic market through cutting-edge technologies, has created two FDA-cleared products (the NeuroCap(TM) and NeuroEEG(TM)) that are nothing like other brain-computer interface (“BCI”) solutions in the market. It has been observed that “data collected from consumer-centric, low-cost BCIs are typically not as efficient or as pristine as that retrieved from research-grade conventional wired EEGs (electroencephalograms),” notes a recent article. “Many of the BCIs on the market are not gelled so that the consumer can easily fit the product themselves. They have far fewer electrodes and are designed for the ease of the…

Continue Reading

ThursdayApr 29, 2021 2:01 pm

BioMedNewsBreaks – Healthy Extracts Inc. (HYEX) Continues to Strengthen Position in Plant-Based Health Industry

Healthy Extracts (OTCQB: HYEX) is committed to growth and has aligned its operations to focus on the plant-based health industry. Reflecting this focus, HYEX changed its name from Grey Cloak Tech to align with the company’s objectives and a “Live Life Young Again” strategy. “The company is making remarkable strides to strengthen its market positions in the plant-based health industry through its two key subsidiaries, the science-based BergaMet North America and Ultimate Brain Nutrients (‘UBN’),” reads a recent article. The company also achieved significant accomplishments in 2020, including a 71% increase in recorded gross revenue, despite the COVID pandemic, as…

Continue Reading

WednesdayApr 28, 2021 9:36 am

BioMedNewsBreaks – RYAH Group Inc. to Begin Trading on CSE under RYAH Ticker

RYAH Group (formerly known as Prime Blockchain Inc.) has announced that, beginning Tuesday, May 4, its common shares will begin trading on the Canadian Securities Exchange (“CSE”) under the ticker symbol RYAH. In accordance with CSE policies, the company has filed the required listing statement on SEDAR. RYAH just recently closed a reverse takeover transaction of Potbotics Inc., consisting of a triangular merger between the company (formerly Prime Blockchain, Inc.), Potbotics and a wholly owned Florida subsidiary of the company. “This is another major step in our journey in transforming patient care through our remote, connected devices and data analytics,…

Continue Reading

TuesdayApr 27, 2021 3:08 pm

BioMedNewsBreaks – Predictive Oncology Inc.’s (NASDAQ: POAI) Helomics Featured in DojoLIVE! Interview

Predictive Oncology’s (NASDAQ: POAI) subsidiary company, Helomics, was recently featured on DojoLIVE!, an engaging podcast and interview forum that brings together technology, business and thought leaders from a wide range of industries. The company’s Chief Technical Officer, Mark Collins, PhD, joined the interview to discuss what Helomics is bringing to the table in the field of cancer research in the podcast titled “Can We Cure Cancer with Artificial Intelligence?” “At Helomics, we have a nice convergence of data that we’ve gathered from testing live tumors, tumors outside the patient body, on drugs, standard of care drugs, normal drugs that you…

Continue Reading